Dror Bashan - Oct 19, 2023 Form 4 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Dror Bashan
Stock symbol
PLX
Transactions as of
Oct 19, 2023
Transactions value $
$90,484
Form type
4
Date filed
10/20/2023, 06:50 AM
Previous filing
Aug 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLX Common Stock Purchase $67.7K +48.4K +71.16% $1.40 116K Oct 19, 2023 Direct
transaction PLX Common Stock Purchase $22.7K +16.1K +13.86% $1.41 133K Oct 19, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.